Additionally, all-trans-retinoic acid, used for the treatment of acute promyelocytic leukemia treatment, suppressed breast cancer growth probably by inhibition of PIN1, being potentially an applicable approach for Notch inhibition when it is positively regulated by PIN1 [332]. The gene discussed is PIN1; the disease is acute promyelocytic leukemia.